Determination and evaluation of serum monosaccharides in patients with early-stage lung adenocarcinoma  

作　　者：Wenhao Su Cui Hao Yifei Yang Pengjiao Zeng Huaiqian Dou Meng Zhang Yanli He Yiran Zhang Ming Shan Wenxing Du Wenjie Jiao Lijuan Zhang 

机构地区：[1]Department of Thoracic Surgery,Affiliated Hospital of Qingdao University,Qingdao,Shandong 266003,China [2]Systems Biology&Medicine Center for Complex Diseases,Center for Clinical Research,Affiliated Hospital of Qingdao University,Qingdao,Shandong 266003,China

出　　处：《Chinese Medical Journal》2025年第3期352-354,共3页中华医学杂志(英文版)

基　　金：Natural Science Foundation of China(Nos.30981672585 and 11804151);Natural Science Foundation of Shandong Province of China(Nos.ZR2020QH286 and ZR2020QC059)

摘　　要：To the Editor:Lung cancer remains the leading cause of cancer-related deaths worldwide.[1]Its histological classification includes non-small cell lung cancer(NSCLC),which encompasses adenocarcinoma,squamous cell carcinoma,and large cell carcinoma.Among these,lung adenocarcinoma(LUAD)is the most common subtype.Visceral pleural invasion(VPI)is a significant factor influencing tumor grade and serves as an independent risk factor for the prognosis of patients with lung cancer.However,due to the lack of measurable markers in most cases,it can only be detected through imaging techniques and pathological examinations.

关 键 词：adenocarcinomasquamous cell carcinomaand pleural invasion vpi visceral pleural invasion early stage lung adenocarcinoma large cell carcinomaamong serum monosaccharides prognosis 

分 类 号：R734.2[医药卫生—肿瘤]